108 related articles for article (PubMed ID: 6698657)
1. Acarbose in reactive hypoglycemia: a double-blind study.
Gérard J; Luyckx AS; Lefèbvre PJ
Int J Clin Pharmacol Ther Toxicol; 1984 Jan; 22(1):25-31. PubMed ID: 6698657
[TBL] [Abstract][Full Text] [Related]
2. Effect of acarbose on glucose and insulin response to sucrose load in reactive hypoglycemia.
Richard JL; Rodier M; Monnier L; Orsetti A; Mirouze J
Diabete Metab; 1988; 14(2):114-8. PubMed ID: 3042485
[TBL] [Abstract][Full Text] [Related]
3. Effect of acarbose, pectin, a combination of acarbose with pectin, and placebo on postprandial reactive hypoglycaemia after gastric surgery.
Speth PA; Jansen JB; Lamers CB
Gut; 1983 Sep; 24(9):798-802. PubMed ID: 6350115
[TBL] [Abstract][Full Text] [Related]
4. Effects of acarbose, an alpha-glucosidase inhibitor (Bay G 5421), on orally loaded glucose, maltose and sucrose and on blood glucose control in non-insulin-dependent diabetics.
Hayakawa T; Noda A; Kondo T; Okumura N
Nagoya J Med Sci; 1985 Jan; 47(1-2):35-41. PubMed ID: 3887176
[No Abstract] [Full Text] [Related]
5. The effect of acarbose on insulin sensitivity in subjects with impaired glucose tolerance.
Chiasson JL; Josse RG; Leiter LA; Mihic M; Nathan DM; Palmason C; Cohen RM; Wolever TM
Diabetes Care; 1996 Nov; 19(11):1190-3. PubMed ID: 8908378
[TBL] [Abstract][Full Text] [Related]
6. Long-term treatment with acarbose for the treatment of reactive hypoglycemia.
Ozgen AG; Hamulu F; Bayraktar F; Cetínkalp S; Yilmaz C; Túzún M; Kabalak T
Eat Weight Disord; 1998 Sep; 3(3):136-40. PubMed ID: 10728163
[TBL] [Abstract][Full Text] [Related]
7. Acarbose. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential.
Clissold SP; Edwards C
Drugs; 1988 Mar; 35(3):214-43. PubMed ID: 3286212
[TBL] [Abstract][Full Text] [Related]
8. Delayed gastric emptying occurs following acarbose administration and is a further mechanism for its anti-hyperglycaemic effect.
Ranganath L; Norris F; Morgan L; Wright J; Marks V
Diabet Med; 1998 Feb; 15(2):120-4. PubMed ID: 9507911
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of acarbose in patients with cystic fibrosis and impaired glucose tolerance.
Kentrup H; Bongers H; Spengler M; Kusenbach G; Skopnik H
Eur J Pediatr; 1999 Jun; 158(6):455-9. PubMed ID: 10378391
[TBL] [Abstract][Full Text] [Related]
10. Effect of acarbose on biochemical responses and clinical symptoms in dumping syndrome.
Lyons TJ; McLoughlin JC; Shaw C; Buchanan KD
Digestion; 1985; 31(2-3):89-96. PubMed ID: 3888753
[TBL] [Abstract][Full Text] [Related]
11. Treatment of poorly controlled non-insulin-dependent diabetic patients with Acarbose.
Scott RS; Knowles RL; Beaven DW
Aust N Z J Med; 1984 Oct; 14(5):649-54. PubMed ID: 6397178
[TBL] [Abstract][Full Text] [Related]
12. Acarbose treatment of infant dumping syndrome: extensive study of glucose dynamics and long-term follow-up.
Zung A; Zadik Z
J Pediatr Endocrinol Metab; 2003; 16(6):907-15. PubMed ID: 12948306
[TBL] [Abstract][Full Text] [Related]
13. Reactive hypoglycaemia due to late dumping syndrome: successful treatment with acarbose.
Imhof A; Schneemann M; Schaffner A; Brändle M
Swiss Med Wkly; 2001 Feb; 131(5-6):81-3. PubMed ID: 11383230
[TBL] [Abstract][Full Text] [Related]
14. Glibenclamide pharmacokinetics in acarbose-treated type 2 diabetics.
Gerard J; Lefebvre PJ; Luyckx AS
Eur J Clin Pharmacol; 1984; 27(2):233-6. PubMed ID: 6437842
[TBL] [Abstract][Full Text] [Related]
15. Acarbose and idiopathic reactive hypoglycemia.
Peter S
Horm Res; 2003; 60(4):166-7. PubMed ID: 14530603
[TBL] [Abstract][Full Text] [Related]
16. Blood glucose concentrations and glycosuria during and after one year of acarbose therapy.
Aubell R; Boehme K; Berchtold P
Arzneimittelforschung; 1983; 33(9):1314-8. PubMed ID: 6357206
[TBL] [Abstract][Full Text] [Related]
17. Prolonged and enhanced secretion of glucagon-like peptide 1 (7-36 amide) after oral sucrose due to alpha-glucosidase inhibition (acarbose) in Type 2 diabetic patients.
Seifarth C; Bergmann J; Holst JJ; Ritzel R; Schmiegel W; Nauck MA
Diabet Med; 1998 Jun; 15(6):485-91. PubMed ID: 9632123
[TBL] [Abstract][Full Text] [Related]
18. The use of acarbose in the prevention and treatment of hypoglycaemia.
Lefebvre PJ; Scheen AJ
Eur J Clin Invest; 1994 Aug; 24 Suppl 3():40-4. PubMed ID: 8001627
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetic-pharmacodynamic relationships of Acarbose.
Salvatore T; Giugliano D
Clin Pharmacokinet; 1996 Feb; 30(2):94-106. PubMed ID: 8906894
[TBL] [Abstract][Full Text] [Related]
20. The STOP-NIDDM Trial: an international study on the efficacy of an alpha-glucosidase inhibitor to prevent type 2 diabetes in a population with impaired glucose tolerance: rationale, design, and preliminary screening data. Study to Prevent Non-Insulin-Dependent Diabetes Mellitus.
Chiasson JL; Gomis R; Hanefeld M; Josse RG; Karasik A; Laakso M
Diabetes Care; 1998 Oct; 21(10):1720-5. PubMed ID: 9773737
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
